Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Metabolic disorders
Biotech
FDA considers new liver trial endpoint, sending MASH shares up
The FDA has begun considering a noninvasive diagnostic measure for patients with fatty liver disease, a move that could speed up drug development.
Gabrielle Masson
Aug 28, 2025 11:25am
Novo seeks obesity refresh with $550M Replicate deal
Aug 28, 2025 7:00am
Terns vows to stop funding metabolic disease trials beyond 2025
Aug 6, 2025 6:20am
Sanofi pens $395M China pact for Arrowhead metabolic med
Aug 1, 2025 7:21am
Turkish bank invests $39M in Harvard next-gen obesity antibodies
Jun 16, 2025 1:07pm
Boy with rare disease 'thriving' after 1st custom gene therapy
May 15, 2025 1:00pm
